In a new study in Cell Discovery, Chen-Yu Zhang's group at Nanjing University and two other groups from Wuhan Institute of Virology and the Second Hospital of Nanjing present a novel finding that ...
Data support the addition of daratumumab to standard lenalidomide maintenance in patients with newly diagnosed multiple myeloma following transplant. Minimal residual disease (MRD)–negative conversion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results